Kentucky Administrative Regulations › Title 810 - PUBLIC PROTECTION CABINET - KENTUCKY HORSE RACING COMMISSION › Chapter 8 - Medication Guidelines › Section 810 KAR 8:010 - Medication; testing procedures; prohibited practices

Current through Register Vol. 51, No. 1, July 1, 2024
RELATES TO:
				KRS
				230.215,
				230.225,
				230.240,
				230.260,
				230.265,
				230.290,
				230.320,
				230.370
NECESSITY, FUNCTION, AND CONFORMITY:
				KRS
				230.215(2),
				230.260(8), and
				230.320 authorize the Kentucky
				Horse Racing Commission to promulgate administrative regulations prescribing
				conditions under which all legitimate horse racing and wagering thereon is
				conducted in Kentucky.
				KRS
				230.240(2) requires the
				commission to promulgate administrative regulations restricting or prohibiting
				the administration of drugs or stimulants or other improper acts to horses
				prior to the horse participating in a race. This administrative regulation
				establishes requirements and controls in the administration of drugs,
				medications, and substances to horses, governs certain prohibited practices,
				and establishes trainer responsibilities relating to the health and fitness of
				horses.
Section 1. Definitions.
(1) "AAS" or "anabolic steroid" means an
			 anabolic androgenic steroid.
(2)
			 "Administer" means to apply to or cause the introduction of a substance into
			 the body of a horse.
(3)
			 "Commission laboratory" means a laboratory chosen by the commission to test
			 biologic specimens from horses taken under the supervision of the commission
			 veterinarian.
(4) "Location under
			 the jurisdiction of the commission" means a licensed race track or a training
			 center as described in
			 KRS
			 230.260(5).
(5) "Positive finding" means the commission
			 laboratory has conducted testing and determined that a drug, medication, or
			 substance, the use of which is restricted or prohibited by this administrative
			 regulation,
			 810 KAR 8:020,
			 810 KAR 8:025, or
			 810 KAR 8:040, was present in the
			 sample.
(a) For the drugs, medications, or
			 substances listed in this administrative regulation,
			 810 KAR 8:020, or
			 810 KAR 8:025, for which an
			 established concentration level is provided, it shall be necessary to have a
			 finding in excess of the established concentration level as provided for the
			 finding to be considered a positive finding.
(b) Positive finding also includes:
1. Substances present in the horse in excess
			 of concentrations at which the substances could occur naturally; and
2. Substances foreign to a horse that cause
			 interference with testing procedures.
(6) "Primary sample" means the primary sample
			 portion of the biologic specimen taken under the supervision of the commission
			 veterinarian to be tested by the commission laboratory.
(7) "Split sample" means the split sample
			 portion of the biologic specimen taken under the supervision of the commission
			 veterinarian to be tested by the split sample laboratory.
(8) "Split sample laboratory" means the
			 laboratory approved by the commission to test the split sample portion of the
			 biologic specimen from horses taken under the supervision of the commission
			 veterinarian.
(9) "Test barn" means
			 a fenced enclosure sufficient in size and facilities to accommodate the
			 stabling of horses temporarily detained for obtaining biologic specimens for
			 testing.